MedTrace Logo

Comparison of Harmoknee Versus Bounding Exercise Protocol in Football Players

NCT07331636 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-01-12

No results posted yet for this study

Summary

This is a randomized clinical trial will recruit male football players aged 18-30 years who regularly participated in sports more than 3 years, with a BMI between 18.5-24.9 kg/m².Athletes with smoking habits, those following other specialized training programs, or those taking any drugs that could affect their performance, and had musculoskeletal injury in past 6 months will be excluded. The sample size will be 36 and participants will randomly divided into two groups (18 in each group): Group A: 8-week Harmoknee program, 3 sessions per week (45 minutes each, including warm-up and cool down). Group B: 8-week Bounding program, following the same schedule. The study will measure strength (1RM Test), balance (Star Excursion Test), agility (T-Test), and muscle power (5 Jump Test) at two points: pre-test (before starting) and post-test (after 8 weeks).

Conditions

  • Sports Physical Therapy

Interventions

OTHER

Harmoknee protocol ( Group A )

Group A will be selected randomly and assigned to 8-week Harmoknee exercise program 3 sessions per week, each lasting 45 minutes (5mins warm-up and 5mins cool down) for assessment of strength and balance.

OTHER

Bounding protocol ( Group B )

Group B will be selected randomly and assigned to 8week Bounding exercise program 3 session per week, each lasting 45 minutes (5mins warm-up and 5mins cool down) for assessment of strength, balance, agility and muscle power.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Hadiqa Mishal, DPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-21
Primary Completion
2025-10-02
Completion
2025-11-02

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07331636 on ClinicalTrials.gov